Sunday, September 6, 2026
PS-19 Session 140, 12:30 - 14:00 Poster session: Decoding COPD through biomarkers
PA1579 Smoking-Associated Changes of Extracellular Vesicles in Plasma and Induced Sputum of COPD Patients and Healthy Controls.
Authors: Meike Müller, Shabnam Wetzel, Tonia Bargmann, Larissa Marie Kasperek, Jens M. Hohlfeld
PS-35 Session 158, 12:30 - 14:00 Poster session: Metabolic pathways in pulmonary fibrosis
PA1931 Buloxibutid (C21) activates the angiotensin II type 2 receptor in alveolar epithelial type II cells, increasing MMP‑13 associated with fibrosis resolution in idiopathic pulmonary fibrosis.
Authors: Johan Raud, Ahmed Mousa, Karin von Wachenfeldt, May Hassan, Christina Hesse, Katherina Sewald, Göran Tornling
PS-36 Session 72, 08:00 - 09:30 Poster session: Translational research in pulmonary fibrosis
PA869 Mechanotransduction measurements in fibrotic human precision-cut lung slices to reveal drug-induced tissue softening mechanisms.
Authors: Sebastian Konzok, Lena Willmer, Jae Hun Kim, Kevin Schmidt, Lavinia Neubert, Christopher Werlein, Patrick Zardo, Sirine Bellou, Briana Peterson, Katherina Sewald, Ramaswamy Krishnan, Christina Hesse
Monday, September 7, 2026
PS-9 Session 378, 12:30 - 14:00 Poster session: Molecular mechanisms and clinical strategies in interstitial lung diseases
PA4365 Late Breaking Abstract - Tankyrase inhibition demonstrates anti-fibrotic effects in preclinical pulmonary fibrosis models.
Authors: Jo Waale, Shoshy A. Brinch, Ida Johnsen, Lena Willmer, Ole V. Bjornstad, Teresa Lucifora, Karl M. F. Forbord, Maria Candamo-Lourido, Maureen T. Meling, Ingrid L. Morken, Martin F. Strand, Danny Jonigk, Patrick Zardo, Hans G. Fieguth, Christina Hesse, Mark A. Skarsfeldt, Morten A. Karsdal, Erika Ferrari, Paola Occhetta, Roberta Visone, Stephen Jordan, Joseph Lee, Harry Holton, Simon Rayner, Anita Wegert Wegert, Simon Cruwys, Stefan Krauss
PS-31 Session 243, 08:00 - 09:30 Poster session: Translating lung cancer: exploring new pathways on pathogenesis, treatment, resistance and toxicity
PA2952 Anti-CD39 modulates macrophages and T cells in the patient-derived ex vivo tumor lung.
Authors: Tonia Bargmann, Lena Stowasser, Maximilian Schinke, Nico Lachmann, Sebastian Konzok, Louisa Jürgen, Christopher Werlein, Patrick Zardo, Lavinia Neubert, Danny Jonigk, Hans-Gerd Fieguth, Katherina Sewald, Susann Dehmel, Armin Braun
PS-34 Session 364, 12:30 - 14:00 Poster session: Viral respiratory infections: virome, immunity and sequelae
PA4102 Characterization of the HPIV3-induced microRNA landscape and its functional impact on viral replication in primary human airway epithelia.
Authors: Fabian Röpken, Philippe Vollmer Barbosa, Kevin Schmidt, Jan Fiedler, Katherina Sewald, Franziska Dahlmann, Armin Braun
Tuesday, September 8, 2026
PS-9 Session 469, 08:00 - 09:30 Poster session: Regulatory mechanisms underlying lung pathology
PA5473 SP-D and sRAGE in Particles in Exhaled Air of Smokers and Non-Smokers with COPD and Healthy Participants.
Authors: Max Gerlach (Hannover, Germany), Christina Gress, Meike Müller, Jens Hohlfeld